HomeLIMN • NASDAQ
add
Liminatus Pharma Inc
Previous close
$0.17
Day range
$0.16 - $0.19
Year range
$0.16 - $33.66
Market cap
7.85M USD
Avg Volume
2.73M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | — | — |
Net income | -8.17M | -3,467.22% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | 10.33M | -58.27% |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | -0.48 | — |
Return on assets | -238.31% | — |
Return on capital | 51.55% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.17M | -3,467.22% |
Cash from operations | -386.85K | -174.36% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | — | — |
Free cash flow | 7.19M | — |
About
Headquarters
Website
